Apricus Biosciences Inc news

   Watch this stock
Showing stories 1 - 10 of about 24   

Articles published

APRI 2.38 -0.01 (-0.42%)
price chart
Strength Seen in Apricus Biosciences (APRI): Stock Soars 18.9%
Apricus Biosciences, Inc. (APRI - Snapshot Report) was a big mover last session, as the company saw its shares rise almost 19% on the day.
Related articles »  
Strength Seen in Apricus Biosciences (APRI): Stock Soars 18.9% - Tale of the ...
Apricus Biosciences, Inc. ( APRI ) was a big mover last session, as the company saw its shares rise almost 19% on the day.
Related articles »  
Eye Catching Stocks: Apricus Biosciences Inc (APRI), Akebia Therapeutics Inc ...
Apricus Biosciences Inc (NASDAQ:APRI) shares jumped more than 17 percent today after the pharmaceutical company announced national phase sanction for its Vitaros treatment in Luxembourg.
Apricus Biosciences (APRI) Completes First Shipment of Vitaros to UK
Apricus Biosciences, Inc. (Nasdaq: APRI) announced that Takeda Pharmaceuticals International GmbH, the Company's partner in the United Kingdom, has accepted the first shipment of Vitaros, Apricus' novel topical on-demand treatment for erectile ...
Apricus Biosciences' Partner in the United Kingdom Accepts First ...  Wall Street Journal
Related articles »  
Stocks Breaking Out: Zogenix (ZGNX), Apricus Biosciences (APRI), Interactive ...
Zogenix, Inc. (NASDAQ:ZGNX) flew up 20.51% after updating the status of its severe pain medication Zohydro ER in Massachusetts.
Unusual Volume at NASDAQ: Advent Software (NASDAQ:ADVS), China XD ...  Gaining Green
Former Yahoo COO gets $58M; Apricus Biosciences Partner Takeda ...  Baystreet.ca
Related articles »  
Apricus Biosciences and Its European Partners to Sponsor Symposium on ...
SAN DIEGO, April 7, 2014 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a pharmaceutical company focusing on the development and commercialization of novel therapeutics for men's and women's health, today announced that the ...
Related articles »  
Apricus Biosciences Announces National Phase Approval for Vitaros in ...
Apricus Biosciences, Inc. (Nasdaq: APRI), a pharmaceutical company focusing on the development and commercialization of novel therapeutics for men's and women's health, today announced that the Ministry of Health of Luxembourg has granted national ...
Apricus Biosciences Announces National Phase Approval for Vitaros(R) in ...  Wall Street Journal
Related articles »  
Apricus Biosciences Expands Senior Management Team, Appointing Neil C ...
SAN DIEGO, March 20, Mar 20, 2014 (GLOBE NEWSWIRE via COMTEX) -- Apricus Biosciences, Inc. (NASDAQ:APRI) , a pharmaceutical company focusing on the development and commercialization of novel therapeutics for men's and women's health, today ...
Related articles »  
Eye-Catching Stocks � Zalicus, (NASDAQ: ZLCS), Zogenix, (NASDAQ: ZGNX ...
Apricus Biosciences Inc (NASDAQ:APRI) reported 1.22 million shares were exchanged during the last trade, while the average volume is about 245,744 shares.
Gaining Investiture Session Stocks: Zalicus Inc (Nasdaq:ZLCS), Zogenix Inc ...  Galaxy Stocks
Unusual 11 Mid-Day Movers 04/16: (ZLCS) (AKBA) (IMGN) Higher; (XGTI) (AEM ...  StreetInsider.com (subscription)
Related articles »  
News Buzz- Zalicus Inc (NASDAQ:ZLCS), Zogenix, Inc. (NASDAQ:ZGNX ...
Las Vegas, NV - April 17, 2014 - (TechSonian) �A biopharmaceutical company, Zalicus Inc(NASDAQ:ZLCS) discovers and develops new treatments for patients suffering from pain.